SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vertex Pharmaceuticals (VRTX) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (370)11/29/1999 10:34:00 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 1169
 
Indeed, very nice deal.

1/3 of the worldwide (ex Japan) clinical expense (which are >80% of the total drug development expense) for ~10% of world market (with 20% royalty). Who can ask more for preclinical staff?

Buy any chance, do you know which company is leader in *aye care and cleaning staff*? Glasses. lens,...and that sorts of things.
I want to hedge or balance my VRTX position, figure indicate that WS my order big supply very soon.